# US 6,730,475 B1 · Methods of diagnosis and treatment of meniere disease

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 6,730,475 B1
- Document ID: US6730475B1
- Status: Granted
- Kind: B1
- Application number: 09/579,288
- Filed: 2000-05-25
- Granted: 2004-05-04
- Earliest claimed: 1999-05-26
- Assignees: The Brigham and Women's Hospital, Inc.; University of Antwerp
- Inventors: Nahid Robertson; Cynthia Morton; Guy Van Camp; Erik Fransen; Paul Van de Heyning
- Web page: https://patentgrep.com/patent/US6730475B1

## CPC

- C07K 14/47: from mammals
- C12Q 1/6827: for detection of mutation or polymorphism
- C12Q 1/6883: for diseases caused by alterations of genetic material
- G01N 2800/14: Disorders of ear, nose or throat
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

The invention features methods of diagnosing and treating Meniere disease. The invention also features kits and probes for diagnosing Meniere disease.

## Claims

### Claim 1

A method of identifying an individual at risk for Meniere disease, comprising:
providing an individual at risk for Meniere disease;
amplifying a nucleic acid sample from the individual which includes at least a portion of the gene encoding the polypeptide of SEQ ID NO:2, wherein the amplified portion of the gene includes residue 51 of SEQ ID NO:2, and
detecting in the individual a genetic lesion in the gene that encodes a polypeptide comprising SEQ ID NO: 2, wherein the lesion is an insertion, a deletion, or a substitution of one or more nucleotides encoding the proline at residue 51 of SEQ ID NO:2, and wherein the presence of the lesion identifies an individual at risk for Meniere disease.

### Claim 2 (depends on 1)

The method of claim 1, wherein the lesion is a deletion or substitution of a cytosine at nucleotide 151 of a COCH5B2 coding sequence of SEQ ID NO:1, or is an insertion at nucleotide 151 of a COCH5B2 coding sequence of SEQ ID NO:1.

### Claim 3 (depends on 1)

The method of claim 1, wherein the lesion is a substitution.

### Claim 4 (depends on 3)

The method of claim 3, wherein the substitution is of a cytosine at nucleotide 151 of a COCH5B2 coding sequence of SEQ ID NO:1.

### Claim 5 (depends on 1)

The method of claim 1, further comprising contacting the amplified sample from the individual with an agent capable of detecting the genetic lesion in the gene.

### Claim 6 (depends on 5)

The method of claim 5, wherein the agent is a nucleic acid probe.

### Claim 7 (depends on 6)

The method of claim 6, wherein the probe is a labeled probe.

### Claim 8 (depends on 6)

The method of claim 6, wherein the nucleic acid probe comprises at least 10 nucleotides from the nucleotide sequence of SEQ ID NO:4.

### Claim 9 (depends on 6)

The method of claim 6, wherein the probe comprises the nucleic acid sequence of SEQ ID NO:6, or a portion thereof.
